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Abstract
Background: It has been suggested that coffee may affect the gut-brain axis with conflicting outcomes. Moreover,
there is insufficient evidence to determine whether the type or temperature of coffee consumed will have a
different impact on the gut-brain axis. The purpose of this study was to investigate the effects of acute coffee
consumption on the following: 1. self-reported GI symptoms and salivary gastrin, 2. stress indices [salivary cortisol
and alpha-amylase (sAA)] and psychometric measures, and 3. blood pressure (BP), in healthy, daily coffee
consuming individuals in non-stressful conditions.
Methods: This was a randomized, double blind, crossover clinical trial, in which 40 healthy individuals (20 men,
20 women), 20–55 years of age, randomly consumed four 200 ml coffee beverages containing 160 mg caffeine
(hot and cold instant coffee, cold espresso, hot filtered coffee), 1 week apart. Salivary samples and psychometric
questionnaires were collected at baseline and post-coffee consumption at 15,30, and 60 min for salivary gastrin and
sAA measurements and at 60,120, and 180 min for cortisol measurements. BP was measured at beginning and end of
each intervention. ClinicalTrials.gov ID: NCT02253628
Results: Coffee consumption significantly increased sAA activity (P = 0.041), with significant differences only
between cold instant and filter coffee at 15 and 30 min post-consumption (P < 0.05). Coffee temporarily
increased salivary gastrin, without differences between coffee types. Coffee did not affect salivary cortisol or
self-reported anxiety levels. Coffee consumption significantly increased BP, within the healthy physiological
levels, in a gender specific manner at the end of the experimental periods, without differences between
coffee types.
Conclusion: Acute coffee consumption in non-stressful conditions activated sAA and BP but not salivary
cortisol, indicating activation of the sympathetic nervous system. Post-coffee sAA increase without a
concomitant cortisol increase may also indicate that coffee may have some anti-stress properties.
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Background
Coffee is a widely consumed, pharmacologically active
beverage, which has been suggested to affect the gut-
brain axis with conflicting outcomes. The gut-brain axis
affects a number of physiological processes that result in
satiety and food intake as well as wellbeing and mood
and may also relate to gastrointestinal (GI) function
and/or GI disturbances [1, 2]. Visualization of food,
anticipation of eating and perceived stress [3] initiate
profound changes in digestive function that are charac-
terized by the release of a variety of GI hormones,
including gastrin, which lead to gastric acid secretion
[1]. In some studies, the coffee-mediated increased
gastric acid secretion [4] has been associated with GI
disturbances, such as gastroesophageal reflux disease
(GERD), epigastric pain, reflux, and heartburn [5].
However, results from clinical and epidemiological trials
have shown that coffee consumption has protective
effects on GI function with no associations with gastric
ulcer, duodenal ulcer, reflux esophagitis, reddish streaks,
and non-erosive reflux disease [6–8]. Furthermore, the
stimulation and interrelation of the gut-brain axis may
explain why some people with a healthy, functioning GI
system experience symptoms such as increased anxiety,
abdominal pain or discomfort, and GERD upon nutrient
or coffee ingestion; these symptoms cannot be medically
explained and are unrelated to coffee consumption and
overall dietary pattern [1, 3, 9–11].
Gastrin, which is secreted in response to a meal [12]
and can be measured in saliva [13], thus allowing it to
be evaluated in non-stressful conditions, is one of the
hormones regulating the rhythm of gastric acid secretion
[14]. Some studies [15–19], but not all [18, 20, 21], have
shown that coffee consumption (independently of caf-
feine content) increases gastrin secretion, regardless of
coffee temperature (cold, warm, hot) [22].
Some studies [23–26], but not all [27–29], have suggested
that caffeinated coffee may activate the hypothalamic-
anterior pituitary-adrenocortical (HPA) axis, increasing the
secretion of stress hormones, i.e., cortisol, in a gender-
dependent manner [30], as well as temporarily increasing
blood pressure (BP), even in small caffeine doses [31],
and basal metabolic rate [32]. It has been reported
that from all the GI hormones involved in gastric
acid secretion, only gastrin concentrations follow the
behavior of cortisol; because both hormones increase
after the physiological stress experienced by athletes
during different types of competitions without, however,
reaching the levels reported for GI pathologies [33].
Moreover, a few studies [34], but not all [35], have
suggested that caffeinated coffee may activate the sym-
pathetic nervous system (SNS), via secretion of saliv-
ary alpha-amylase (sAA) [36–40], an enzyme
involved in polysaccharide digestion [41]. sAA is a
convenient marker and is easily collected and
measured in saliva [36, 42–44]; it is recognized as
both a soothing/relaxation index [45] and a stress
response marker [36].
Therefore, due to the limited and contradictory find-
ings of the literature, the purpose of this study was to
examine the effects of acute consumption of different
types and temperature of coffee (hot and cold instant
coffee, cold espresso and hot filtered coffee), containing
equal amounts of caffeine in non-stressful conditions on
1. self-reported GI and salivary gastrin; 2. stress indices
(salivary cortisol, sAA and self-reported anxiety levels);
and 3. BP in healthy men and women. The study is the
first such examination, to our knowledge, and was
performed in the context of the limited and contradict-




Forty healthy volunteers (20 men and 20 women),
20–55 years old, with body mass index (BMI) ≥18.5
and <27 kg/m2, who consumed coffee daily and did
not object to consuming cold coffee, participated in
this randomized, double blind, crossover study. Volunteers
had to have stable body weight for at least 1 month before
entering the study. Exclusion criteria included consuming
breakfast >3 days/week (so that it would not be uncom-
mon practice for the volunteers to consume coffee with-
out food and remain on an empty stomach for many
hours), daily intake of ≥500 mg caffeine, a psychological
state strongly influenced by outside factors (e.g. moving to
new home, work change, separation from a loved one,
etc.), attempting to lose weight at the time of the study,
smoking, intense physical activity (>4 h per day), medical/
drug therapy, depression, medical conditions (i.e., diabetes
mellitus, hypertension, and similar factors).
All volunteers signed a consent form and the research
protocol was approved by the Bioethics Committee of the
Agricultural University of Athens. The study was com-
pleted at the Human Nutrition Unit of the Department of
Food Science and Human Nutrition of Agricultural
University of Athens.
Experimental procedure
All studies started between 08.30 and 09.00 h. All
volunteers completed a medical and demographic
questionnaire on their initial visit. Each volunteer
attended four separate experimental sessions, 1 week
apart. For allocation of the participants, a computer-
generated list of random numbers was used (http://
www.random.org/sequences/). One person, not involved
in data handling and analysis, was responsible for the test
coffee allocation. The coffee was served in a paper cup
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covered with a lid, and neither the participants nor the
investigators were aware of the sequence or the content of
paper cups. The crossover design was selected to limit the
inter-subject variability between the interventions [46].
At each experimental session, 200 ml of coffee bever-
age was consumed and contained 160 mg caffeine and
7.5 g white sugar: [1. hot instant coffee (Nescafé Classic,
Nestlé); 2. cold instant coffee (Nescafé Classic, Nestlé);
3. cold espresso (Buondi prestige, Nestlé); and 4. hot
filtered coffee (Nestlé Professional Plantage Filter Coffee,
Nestlé]. Volunteers came to the Human Nutrition Unit
at the same time and day of the week, ruling out the
possibility of confounding effects of different days of the
week (i.e. Friday may be a less stressful day than Monday
for some people). The day preceding the test coffee, the
volunteers were required to a) not consume anything
containing caffeine, thus ruling out additive results if the
previous day’s caffeine had been not fully metabolized, b)
not consume alcohol, thus limiting the possibility of dehy-
dration status effects [47], c) avoid exercise, thus reducing
the possibility of dehydration status effects [48], d) get
adequate sleep the previous night (~7 h), e) fast for 8 h, f)
consume approximately the same foods the day before the
test as consumed on the day preceding the 1st test bever-
age, in the same quantities and times of day, thus prevent-
ing confounding effects from the previous day’s dietary
intake. To accomplish this, a photocopy of the base-
line 24 h recall obtained was given to each volunteer.
Volunteers were not allowed to perform physical activity
or consume food/liquids during the study and were asked
to remain seated at all times.
Biochemical analysis and salivary technique
The caffeine content of the coffee beverages was deter-
mined using high performance liquid chromatography
(HPLC) [49]. Fasting salivary samples for measurement
of salivary gastrin, salivary cortisol and sAA were
collected 15 min after the volunteers’ arrival. Immedi-
ately afterward, the volunteers consumed one of the four
test coffee beverages, and salivary samples were collected
at 15, 30, and 60 min after coffee consumption for
gastrin and sAA evaluation and at 60, 120 and 180 min
for cortisol evaluation.
Salivary samples were collected using the «Salivette»
method (Sarstedt AG and Co, Germany). Before the
collection of the salivary samples, volunteers washed
their mouths well with clear water to avoid contamin-
ation of saliva samples with food components and to
avoid activation of salivary flow or protein production by
gustatory stimuli [44]. Then, they were asked to remove
the cotton from the tube and to move it around in a
circular pattern for approximately 1 min to collect
saliva from all glands [44]. The tubes were stored
immediately at – 20 °C.
Salivary gastrin was measured with an ELISA immu-
noenzymic test (Abcam ltd, UK), sAA with kinetic
enzyme assay kit (Salimetrics, UK) and salivary cortisol
with an ELISA immunoenzymic test (Salimetrics, UK).
All biochemical measurements were performed at
Agricultural University of Athens.
Anthropometric and blood pressure (BP) measurements
The body weight and height of volunteers were measured,
and the BMI was calculated. Body composition analysis
was performed using the bioelectrical impedance method
(Tanita BC-408).
BP was measured at the beginning and end (180 min)
of each intervention with a sphygmomanometer 3
times, with a 2 min interval between each measurement
and with each participant being seated after 15 min of
relaxation. The final value used was the mean of the
three measurements.
Dietary intake and physical activity analysis
Dietary intake was assessed with the use of a 24-h recall
at every visit, for evaluation of the last 24 h dietary
intake; a semi-quantitative food frequency questionnaire
(FFQ), for evaluation of long-term dietary intake [50];
and a semi-quantitative modified FFQ that included only
foods and beverages containing caffeine, for evaluation
of the daily intake of caffeine (including all varieties of
coffee, both caffeinated and decaffeinated, teas, caffein-
ated sodas, energy drinks, and foods/beverages contain-
ing chocolate). Dietary intake was analysed using the
Diet Analysis Plus software (ESHA Research, OR, USA).
Caffeine intake was calculated using the United States
Department of Agriculture National Nutrient Database
for Standard Reference and composition information
from the food industry.
Physical activity was assessed with the use of a phys-
ical activity questionnaire [Harokopio Physical Activity
Questionnaire (HPAQ)] [51] for evaluation of the
weekly and daily energy expenditure. The physical
activity questionnaire was analyzed using the metabolic
equivalent of activities [52].
Psychometric evaluations
Participants’ psychological state was evaluated with the
use of 1. the Zung self-rating anxiety scale, which
consisted of 20 questions, aimed to assess how the indi-
vidual feels at the time of questioning [53], and was
collected at baseline and 15, 30 and 60 min post-coffee
consumption; 2. the Zung self-rating depression scale
[54], collected at baseline; 3. the PSS-14 perceived stress
questionnaire, which was validated for the Greek popula-
tion [55] and collected at baseline; and 4. a self-reported
scale questionnaire, which consisted of 29 questions with
a score of 1 = not at all to 10 = very, evaluating reactions/
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symptoms, collected at baseline and at 15, 30, 60, 120 and
180 min post-coffee consumption. The self-reported scale
questionnaire was developed by the clinical psychologist
of our team and was used to assess GI symptoms and the
psychological state of participants. [Questions: 1. I feel
tremble; 2. I feel calm/relaxed; 3. I feel tension; 4. I feel
that I have a migraine/headache; 5. I feel that my heartbeat
is fast/racing; 6. I feel irritated/nervous; 7. I feel abdominal
discomfort; 8. I feel stomach discomfort; 9. I feel abdom-
inal pain; 10. I feel stomach ache; 11. I feel constipated;
12. I feel that coffee improves my bowel function; 13. I feel
abdominal bloating/distension; 14. 1 feel like vomiting; 15.
I feel dyspepsia; 16. I feel that coffee helps me with diges-
tion; 17. I feel heartburn; 18. I feel that I am having gastro-
esophageal reflux; 19. I feel more energetic; 20. I feel
intense fatigue; 21. I feel that I have difficulty concentrat-
ing; 22. I feel that my concentration is increased; 23. I feel
vigilant; 24. I feel that my memory is better; 25. I feel that
my memory is worse; 26. I feel mentally alert; 27. I feel
that my mood is better; 28. I feel that my mood is worse;
29. I feel stressed/under pressure].
Statistical analysis
Results are presented as the mean ± SEM. Differences
between men and women in the volunteers’ descriptive
characteristics were tested with a t-test for independent
samples and the non-parametric Mann–Whitney test,
depending on normality of the variables’ distribution.
Normality was tested using the Kolmogorov-Smirnov
test, as well as graphical methods (e.g., Q-Q plots) for
the continuous variables. Calculations of areas under the
curve (AUC) for salivary gastrin, salivary cortisol and
sAA were based on the trapezoid rule. Differences in
gastrin, sAA and cortisol concentrations, BP and stress
scores between and among the 4 test coffee beverages,
at the different time points and between genders were
tested using repeated measures ANOVA with two
within-subjects factors, type of coffee (hot instant, cold
instant, cold espresso and hot filtered coffee) and time
(0, 15, 30, 60 min and 0, 60, 120, 180 min respectively)
and gender as an among-subject factor. Because gender
and the respective interactions were not significant in all
cases, except systolic BP, they were removed from the
model. Moreover, for all parameters, one-way repeated
measures ANOVAs were used to investigate differences
between the types of coffee for each time point and for
each type of coffee during the different time points.
Multiple comparisons between the interventions were
tested using the Tukey test. Differences between categor-
ical data were tested using the chi-squared test. All stat-
istical analyses were performed by SPSS (version 20.0,
Chicago, IL, USA). The study had 80 % power (α = 0.05)
to detect differences between dietary groups of 12.6 pg/ml
in gastrin and 0.2 μg/ml in cortisol. For all tests, a P-value
of less than 0.05 was considered to be statistically signifi-
cant. Reporting of the study conforms to CONSORT-
revised along with references to CONSORT-revised and
the broader EQUATOR guidelines [56].
Results
Subjects’ characteristics at baseline are described in
Table 1. Body weight remained stable throughout the
study. All volunteers consumed at least one cup of coffee
per day with similar caffeine intake between men and
women (Table 1). The majority of our volunteers had a
high socioeconomic status and education level, with
42 % of the total sample having obtained a higher educa-
tion degree and/or graduate school degree (Table 1).
The scores on the psychometric questionnaires imply
that our participants had moderately high perceived
stress but normal self-reported anxiety and depression
levels (Table 1).
There was no significant main effect of gender and no
gender x coffee interaction for salivary gastrin, salivary
cortisol, sAA and psychometric evaluations, and there-
fore, our results are presented for the entire sample.
There was no main effect of coffee or coffee x time or
time interactions for self-reported anxiety levels
(Table 2). Moreover, no significant differences were
found between the types of coffee at any time point from
the self-reported scale questionnaire, which was devel-
oped for the purposes of our study and was used to
evaluate reactions/symptoms. Volunteers reported an
average score of 1.0 out of 10 for all the questions
pertaining to negative GI symptoms (i.e., abdominal
discomfort, bloating, dyspepsia, and heartburn), chronic
stress and negative feelings and a score of 9.0 out of
10 for all the questions pertaining to positive feelings
(Data not shown).
At baseline, salivary gastrin concentrations were not
different among the coffee types (Table 2, Fig 1). We
found no significant main effect of coffee or coffee x
time interaction, but did find a significant time inter-
action (P < 0.01) for salivary gastrin. At baseline, the
salivary cortisol concentrations were not significantly
different among coffee types (Table 2, Fig 2a). We found
no significant main effect of coffee or coffee x time
interaction, but did find a significant time interaction
(P < 0.01) for salivary cortisol. At baseline, sAA con-
centrations were not different among coffee types
(Table 2, Fig 2b). We found a significant main effect
of coffee (P = <0.001), a significant coffee x time
interaction (P = 0.003) and a significant time interaction
(P < 0.001) for sAA. sAA concentrations increased signifi-
cantly after consumption of all test coffees (P < 0.001;
Table 2, Fig 2b), peaked at 30 min, and did not significantly
differ between 30 and 60 min post-coffee consumption
(Table 2). At 15, 30, and 60 min post-coffee consumption,
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the sAA concentrations were significantly higher after the
consumption of cold instant coffee compared to filter coffee
(P < 0.05; Table 2), cold instant coffee did not differ from
hot instant coffee, and filter coffee did not differ from cold
espresso (Table 2; Fig 2b). Instant coffee had a significant
higher iAUC for sAA than did filter coffee (P < 0.001) and
hot instant coffee (P = 0.007), without differences between
cold instant coffee and cold espresso or between filter
coffee and hot instant coffee or cold espresso.
Our participants were normotensives at baseline
(Table 1). Coffee consumption increased BP within the
healthy physiological levels at the end of the experimental
periods (Table 3), but without differences between coffee
types. There was a main effect of gender (P < 0.001) and
time (P < 0.001) only for systolic BP (Table 3), but without
a significant main effect of coffee, coffee x time, coffee x
gender or gender x time interactions. There was no
significant main effect of a gender, coffee, or gender x
coffee, or coffee x time interactions, but there was a
significant time interaction (P = 0.010; Table 3) for
diastolic BP.
Discussion
The main findings of this study were that in healthy, daily
coffee consumers, acute consumption of different types of
coffee (instant coffee, espresso and filter coffee), contain-
ing equal amounts of caffeine 1. significantly increased
sAA activity without a concomitant increase in salivary
cortisol, implying a non-gender specific activation of the
SNS in non-stressful conditions and also indicating that
coffee consumption may have some anti-stress properties;
2. temporarily increased salivary gastrin concentrations,
without differences among coffees, but had no effect on
self-reported GI symptoms or other psychometric mea-
sures; and 3. all coffees significantly increased BP, but
within the healthy physiological levels.
In our study, we found that salivary gastrin concen-
trations were only temporarily increased after coffee
consumption, independent of coffee temperature [22],
which is in agreement with some studies [15–19, 57],
but not all [18, 20, 21]. In our study, the salivary gastrin
values were comparable to plasma gastrin levels reported
in other studies [22]. Moreover, contrary to previous
reports [33], we did not find an interrelationship
between salivary gastrin and salivary cortisol in healthy
individuals in non-stressful conditions, indicating that
salivary gastrin concentrations possibly follow the behav-
iour of cortisol only under physiological stress, as in the
case of intense exercise. Furthermore, the discrepancy
between increased salivary gastrin values and the lack of
effect of coffee consumption on self-reported GI distur-
bances/symptoms in healthy, daily coffee consuming
individuals without any previous history of GI problems
is in agreement with others measuring plasma gastrin
[6, 33, 58]; this finding indicates that GI disturbances
are not coffee or gastrin related, but possibly associated
with medium to intense physiological and/or psycho-
logical stress, as has been reported in both clinical trials
Table 1 Volunteers’ descriptive characteristics at baseline (n = 40)
Characteristic Total sample (n = 40) Men (n = 20) Women (n = 20) P1
Age (years) 26.5 (23.0, 34.5) 31 ± 8.7 28 ± 7.8 NS
Body weight (kg) 70.9 ± 15.9 83.7 ± 11.0 58.1 ± 7.4 <0.001
Body Mass Index (kg/m2) 23.6 ± 3.5 25.7 ± 3 21.4 ± 2.4 <0.001
Body fat (%) 22.1 ± 6.9 20.1 ± 6.7 24.2 ± 6.7 NS
Lean body mass (kg) 54.8 ± 12.4 66.2 ± 5.9 43.3 ± 2.7 <0.001
Total body water (kg) 40.1 ± 9.1 48.5 ± 4.3 31.7 ± 2 <0.001
Daily caffeine intake (mg) 109.6 (49.9, 156.9) 120.2 (47.3, 159.5) 99.0 (49.9, 156.9) NS
Daily energy intake (kcal) 1931.4 (1678.6, 2745.6) 2625.2 ± 878.5 1885 ± 437.2 <0.001
Carbohydrates (%) 43.7 ± 9.6 41.1 ± 8.5 46.3 ± 10.1 NS
Protein (%) 17.0 (13.5, 20) 17.8 ± 5.7 16.9 ± 4 NS
Fat (%) 37.9 ± 9.3 40.2 ± 8.1 35.7 ± 10.1 NS
Energy expenditure- HPAQ (kcal) 2400.0 (2070.0, 3128.0) 3061.6 ± 579.6 2070.0 (1643.5, 2203.5) <0.001
Score of the PSS-14 Questionnaire (0–56) 31.8 ± 5.5 32.1 ± 4.3 31.6 ± 6.6 NS
Score of the Zung self-rating anxiety scale questionnaire (20–80) 30.9 ± 4.6 30.9 ± 5.3 31 ± 3.9 NS
Score of the Zung self-rating depression scale questionnaire (20–80) 33.8 ± 6.5 33.2 ± 6.5 34.4 ± 6.6 NS
Systolic blood pressure (mmHg) 122.6 ± 14.4 128.2 ± 12.3 117 ± 14.4 0.012
Diastolic blood pressure (mmHg) 79.4 ± 10.3 83.3 ± 5.8 75.5 ± 12.3 0.015
Data are Means ± SEM, or Median (1st tertile, 3rd tertile)
Abbreviations: NS not statistically significant
P-values < 0.05 were considered as significant
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and population studies [2, 9–11]. Furthermore, it seems
that the interrelationship between GI symptoms, such as
dyspepsia and abdominal pain, and increased plasma
gastrin concentrations after coffee consumption depends
on the individual characteristics and may only be
relevant to a minority of individuals who are sensitive
to caffeine [21, 59].
Cortisol is one of the most important stress hormones
in humans, and increased basal levels of cortisol are con-
sidered to be a valid marker for sustained activation of the
HPA axis. In our study, coffee consumption did not affect
salivary cortisol concentrations in men or in women,
which is in agreement with some studies [60–62], but not
all [25–27, 29, 63]. Our results on the lack of a coffee
effect on salivary cortisol may also be because of the non-
stressful conditions and minimal anxiety levels of our
subjects, as explored during the pre-enrolment screening
of our study. Another study investigating the relationships
between salivary cortisol profiles, job stress, work load
and health in health care workers showed that coffee
accounted for 8.4 % of the cortisol decline during the day
and 15.2 % of the cortisol levels in the evening (2200 h)
[60]. Another study, however, found that healthy adults
taking repeated doses of caffeine during the day had
Table 2 Biochemical indices, self-reported anxiety levels1 at baseline and after coffee consumption in healthy volunteers in
non-stressful conditions (n = 40)
Cold espresso Filter coffee Cold instant coffee Hot instant coffee PA 2
Biochemical indices
Salivary cortisol (mcg/dL)
Baseline 0.31a ± 0.03 0.32a ± 0.02 0.32a ± 0.03 0.30a ± 0.02 NS
60 min 0.24b ± 0.02 0.22b ± 0.01 0.25b ± 0.02 0.23b ± 0.02 NS
120 min 0.23bc ± 0.02 0.20bc ± 0.01 0.20bc ± 0.02 0.21b ± 0.02 NS
180 min 0.19c ± 0.01 0.17c ± 0.01 0.17c ± 0.01 0.18b ± 0.01 NS
PB 3 <0.001 <0.001 <0.001 <0.001
iAUC 11.25 ± 1.35 11.10 ± 1.10 13.41 ± 1.46 11.25 ± 0.98 NS
Salivary alpha-amylase (U/ml)
Baseline 46.53a ± 4.76 49.07a ± 5.44 49.07a ± 5.04 52.69a ± 6.17 NS
15 min 58.93aΑΒ ± 7.05 49.50aΑ ± 5.23 70.27bΒ ± 8.97 53.63aΑΒ ± 5.94 0.030
30 min 94.50bAB ± 10.94 74.81bA ± 7.76 100.44cB ± 11.19 83.41bAB ± 8.67 0.024
60 min 103.54bB ± 10.49 80.45bA ± 8.77 97.35cAB ± 10.44 86.61bAB ± 8.91 0.034
PB <0.001 <0.001 <0.001 <0.001
iAUC 1019.29ab ± 139.47 675.75a ± 83.89 1214.79b ± 167.35 772.67a ± 89.74 <0.001
Salivary gastrin (pg/ml)
Baseline 6.93a ± 1.72 10.54a ± 1.82 9.12a ± 2.18 5.17a ± 1.03 NS
15 min 51.18c ± 5.36 47.53b ± 5.93 60.33b ± 10.40 62.95c ± 8.98 NS
30 min 27.34b ± 4.30 16.06a ± 2.75 21.67a ± 5.61 21.10b ± 3.44 NS
60 min 10.46a ± 3.19 7.74a ± 1.88 12.64a ± 3.43 6.45ab ± 1.35 NS
PB <0.001 <0.001 <0.001 <0.001
iAUC 994.66 ± 74.03 730.16 ± 75.34 1377.81 ± 190.70 1251.22 ± 148.86 NS
Score of the Zung self-reported anxiety scale questionnaire (20–80)
Baseline 28.6 ± 0.7 28.9 ± 0.7 28.3 ± 0.6 27.8 ± 0.7 NS
15 min 28.8 ± 0.6 28.8 ± 0.7 28.8 ± 0.7 27.6 ± 0.6 NS
30 min 29.5 ± 0.7 28.5 ± 0.6 29.2 ± 0.7 27.9 ± 0.6 NS
60 min 29.0 ± 0.6 28.8 ± 0.6 28.9 ± 0.6 28.1 ± 0.6 NS
PB NS NS NS NS
Data are Mean ± SEM
Abbreviations: NS not statistically significant, iAUC incremental area under the curve calculated with the trapezoid rule. Means that have no superscript in
common are significantly different from each other
P-values <0.05 were considered as significant
1Score of the Zung self-reported anxiety scale questionnaire (20–80) (Reference [45])
2PA describes differences between coffee types at a specific time point
3PB describes differences between time points for every coffee type
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Fig. 1 Salivary gastrin concentrations per time and per type of coffee in healthy participants under non-stressful conditions (n = 40). Data are
means ± SEM. P-values < 0.05 were considered as significant
Fig. 2 Salivary cortisol (a) and salivary alpha-amylase (b) concentrations per time and per type of coffee in healthy participants under
non-stressful condition (n = 40). Data are means ± SEM. An asterisk indicates a statistically significant difference between the test coffee
groups (P < 0.05)
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increased cortisol response to caffeine during the after-
noon hours, and the effect was gender dependent; how-
ever, in those consuming caffeine on a daily basis, the
cortisol responses to caffeine were reduced but not elimi-
nated, independently of gender [25]. Another study
showed increased cortisol after coffee consumption only
during an examination period compared to periods with-
out examination [64]. Lastly, another study showed that
caffeine administration in combination with an engaging
non-stressful task decreased salivary cortisol in healthy,
young, male, daily caffeine consumers [35]. The differ-
ences noted between studies may also be explained by the
fact that salivary cortisol responses to caffeine intake
in non-stressful conditions or diverse acute challenge
paradigms show large intra- and inter-individual
variability [65].
In our study, all coffee types, independently of gender,
increased sAA activity with a significant main effect of
coffee, coffee by time and time interactions. Cold instant
coffee increased sAA significantly more than did filter cof-
fee and hot instant coffee; however, cold instant coffee did
not differ from cold espresso, and filter coffee did not
differ from cold espresso or from hot instant coffee. These
findings indicate that the temperature of the coffee bever-
age may affect sAA activity, but this has not been reported
previously in the literature.
It has been shown that sAA activity shows a distinct
diurnal profile pattern with a pronounced decrease
within 60 min after awakening and a steady increase of
activity during the course of the day [43]. Our results
are in partial agreement with some studies showing that
caffeine intake in habitual caffeine consumers signifi-
cantly increases sAA activity [34, 66]. Furthermore,
another study showed that caffeine intake, was the only
statistically significant predictor of higher sAA levels
among nurses at a paediatric intensive care unit [67].
Table 3 Arterial blood pressure at baseline and after coffee consumption in healthy volunteers in non-stressful conditions (n = 40)
Cold espresso Filter coffee Cold instant coffee Hot instant coffee PA 1
Arterial Blood Pressure (mmHg)
Systolic Blood Pressure (mmHg)
Baseline 116.67a ± 1.54 118.21a ± 1.95 116.74a ± 1.95 118.53a ± 1.64 NS
End 120.03b ± 1.76 121.17b ± 1.68 121.34b ± 1.80 122.62b ± 1.87 NS
PB 2 0.009 0.008 NS 0.007
Systolic Blood Pressure (mmHg) in Men (n = 20)
Baseline 120.70a ± 1.81 122.62a ± 2.65 123.07a ± 2.00 122.88a ± 2.07 NS
End 115.95b ± 2.57 115.20b ± 1.96 116.65b ± 2.03 118.81b ± 2.55 NS
PB 0.031 0.048 0.046 0.030
Systolic Blood Pressure (mmHg) in Women (n = 20)
Baseline 112.18a ± 2.08 111.05a ± 2.09 112.80a ± 2.89 113.95a ± 2.16 NS
End 115.95b ± 2.57 115.20b ± 1.96 116.65b ± 2.03 118.81b ± 2.55 NS
PB 0.031 0.048 0.046 0.030
Diastolic Blood Pressure (mmHg)
Baseline 75.27a ± 1.12 77.09a ± 1.35 77.33a ± 1.34 78.15a ± 1.47 NS
End 79.54b ± 1.44 79.05b ± 1.06 79.63b ± 1.15 80.19b ± 1.38 NS
PB <0.001 0.049 0.019 NS
Diastolic Blood Pressure (mmHg) in Men (n = 20)
Baseline 74.90a ± 1.42 76.63a ± 1.72 76.85a ± 1.48 78.44a ± 1.38 NS
End 78.42b ± 1.77 79.83b ± 1.22 79.18b ± 1.30 80.86b ± 1.35 NS
PB 0.022 0.034 0.017 NS
Diastolic Blood Pressure (mmHg) in Women (n = 20)
Baseline 75.33a ± 1.73 78.03a ± 2.00 75.67a ± 1.82 77.23a ± 2.63 NS
End 80.92b ± 2.19 79.43b ± 1.91 78.53b ± 1.70 80.00b ± 2.47 NS
PB <0.001 NS 0.005 NS
Data are Mean ± SEM
Abbreviations: NS not statistically significant
Mean that have no superscript in common are significantly different from each other. P-values <0.05 were considered as significant
1PA describes differences between coffee types at a specific time point
2PB describes differences between time points for every coffee type
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Contrary to our findings, another study showed that
caffeine intake in combination with an engaging non-
stressful task did not affect sAA activity in healthy young
male daily caffeine consumers [35]. However, due to the
limited available literature, it is difficult to explain our
sAA findings in regards to the sAA response to different
coffee types. sAA activity may indicate the activation of
the SNS to a challenge. However, when there is no paral-
lel activation of cortisol, increased sAA activity may also
indicate that the enzyme is a soothing or relaxation
index [45]. Furthermore, our results on the lack of an
effect of coffee consumption on perceived stress and the
other psychometric measures, along with the lack of
effect on salivary cortisol and increased sAA activation,
may be consistent with coffee possessing some anti-
stress properties.
In our study, we found that coffee consumption
significantly increased BP, within the healthy physio-
logical levels, in a gender specific manner in normoten-
sive healthy individuals 3 h post-consumption, without
differences between coffee types; which may be partially
explained by SNS activation. Our results are in agree-
ment with studies showing a temporary hypertensive
coffee effect [35, 64, 68–70], even after small doses of
consumed caffeine (80 mg/day) [31]. However, other
studies have shown that the type of coffee may have a
different impact on BP suggesting that boiled coffee may
cause a higher increase in BP compared to filtered cof-
fee, whereas instant coffee and decaf do not affect BP,
after daily consumption of large coffee doses (>5 cups)
for several days and/or weeks [71, 72]. The results of a
meta-analysis of 6 prospective studies showed a caffeine
dose-dependent positive association (J-shape effect)
between coffee consumption and risk of hypertension,
with the risk slightly increasing due to a small to
medium consumption of 1–3 cups of coffee per day;
however, consumption of 3 or more cups of coffee per
day was not associated with a risk of hypertension [73].
Contrary to the aforementioned results, clinical trials
with >2 weeks duration showed no association between
coffee consumption and BP after daily consumption of
medium to large coffee doses [74]. Similarly, the results
from a meta-analysis of 10 clinical trials and 5 prospect-
ive trials showed that chronic coffee consumption had
no significant effects on BP and hypertension risk, but
the authors also noted that the available data are still of
low quality for drawing safe conclusions [75].
This study is the first, to our knowledge, to investigate
the effects of different types of coffee on self-reported
GI symptoms, salivary gastrin, stress indices such as
salivary cortisol and sAA, self-reported anxiety levels,
and BP in healthy individuals (men and women) in
non-stressful conditions. However, some limitations
should be kept in mind when considering the results.
Concerning salivary gastrin measurements, there is only
one study in the literature showing a positive correlation
between the gastrin measured in plasma and saliva
(rho = 0.899, P < 0.001) [13] and further studies are
needed to confirm these findings. As aforementioned, in
our study the salivary gastrin values were comparable to
plasma gastrin levels reported in other studies [22].
Conclusion
The main findings of this study were that in healthy,
daily coffee consumers, acute consumption of different
types of coffee (instant coffee, espresso and filter coffee)
containing equal amounts of caffeine 1. caused a signifi-
cant activation of the SNS in non-stressful conditions by
increasing sAA concentrations, without concomitant
increases in salivary cortisol and without gender specifi-
city, implying that coffee consumption may have some
anti-stress properties; 2. temporarily increased salivary
gastrin concentrations, without differences among coffees,
but had no effect on self-reported GI symptoms or other
psychometric measures; and 3. increased significantly BP,
within the healthy physiological levels, without differences
between coffee types.
The present results are intriguing and present more
questions than answers with regard to the relationship
between coffee consumption and GI function, stress, sAA
activity, and BP. Nonetheless, these findings suggest that
sAA be considered a valuable biomarker in biobehavioral
studies on the health effects of coffee. In conclusion, the
present study showed that acute coffee consumption
(instant coffee, espresso, filter coffee) increased sAA and
BP, thus activating the SNS, without effects on salivary
cortisol or self-reported anxiety levels. Long-term clinical
trials are needed to confirm our results and also to explore
the coffee-mediated activation of the SNS and its effect on
the gut-brain axis.
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